Results 171 to 180 of about 53,340 (302)

<i>Bacteroides cellulosilyticus</i>-derived 2-hydroxyphenylacetic acid rectifies hepatic lipid homeostasis in MASLD by targeting the PPARγ-CD36 axis. [PDF]

Gut Microbes
Chen K, Yang Z, Peng J, Liu C, Yu Y, Cai X, Liu B, Li S, Chen T, Jung S, Tian Y, Xu Q, Rao X, Wu Z, Wang H, Di Y, Wang L, Wang J, Lee MS, Zou Y, He N, Li S.   +21 more
europepmc   +1 more source

Epigenomic Cascades Across Organs in Metabolic Dysfunction–Associated Steatotic Liver Disease: New Therapeutic Horizons

Obesity Reviews, EarlyView.
ABSTRACT Metabolic dysfunction–associated steatotic liver disease (MASLD) is the most common chronic liver disorder worldwide, affecting approximately one‐third of the population and increasing the risk of severe hepatic and cardiovascular complications.
Shurui Yang, Zhongyu Huang, Sanchun Tan, Fengxia Liang, Li Chen   +4 more
wiley   +1 more source

Macrophage PIM1 Drives Atherosclerosis by Enhancing Foam Cell Formation Via CD36. [PDF]

Arterioscler Thromb Vasc Biol
Beg MA, Luu QQ, Chen V, Wang Y, Xin G, Cui W, Silverstein RL, Chen Y.   +7 more
europepmc   +1 more source

Extracellular Vesicle Surface Protein Profiling in Metabolic Dysfunction-associated Steatotic Liver Disease in Obesity. [PDF]

J Extracell Biol
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is highly prevalent in obesity, but scalable tools for biological risk stratification remain limited. In this cross‐sectional, single‐centre discovery study (MULTISITE), we profiled circulating extracellular vesicle (cEV) surface proteins by EV Array in platelet‐poor plasma from ...
Garcia NA, Kløve-Mogensen K, Cliff KL, Bæk R, Ulanowska M, Quezada JAD, Jørgensen MM, Handberg A, Mellergaard M.   +8 more
europepmc   +2 more sources

Periodontitis and metabolic dysfunction‐associated steatotic liver disease

Periodontology 2000, EarlyView.
Abstract Objective Periodontitis is a chronic inflammatory disease with systemic effects that extend beyond the oral cavity and contribute to systemic immune and metabolic dysregulation. Chronic liver diseases, particularly metabolic dysfunction‐associated steatotic liver disease (MASLD) and its progressive phenotypes, have emerged as major global ...
Rafael Scaf de Molon, Erica Dorigatti de Avila, Davi da Silva Barbirato, Mariana Fampa Fogacci, Jamil Awad Shibli, Anton Sculean, Alpdogan Kantarci   +6 more
wiley   +1 more source

CD36: bridging metabolism, inflammation, and reproduction. [PDF]

NPJ Metab Health Dis
Liu Q, Yang D, Cai S, Zou Y, Yin T, Diao L.   +5 more
europepmc   +1 more source

CD36 molecule (thrombospondin receptor) (SCARB3; FAT; CD36) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Molecular characterization of CD36 deficiency in blood donors of Middle Eastern and African origin reveals transcript‐level defects beyond genomic variants

Transfusion, EarlyView.
Abstract Background The increasing diversity of blood donor populations has created new challenges for transfusion services worldwide. The identification of donors lacking relevant high‐prevalence antigens is becoming increasingly important to ensure compatible blood products for alloimmunized patients and to support the development of rare donor ...
Sarah Petermann, Inga Stellmacher, Brigitte K. Flesch, Tanja Rehling, Irina Häcker, Marc F. Schetelig, Alexander Carbol, Lambros Kordelas   +7 more
wiley   +1 more source

Comment on 'Validation and Modeling of Flow Cytometric CD36 Coefficient of Variation (CV) Analysis in the Diagnosis of Lower- Risk Myelodysplastic Syndromes'

Turkish Journal of Hematology
Hinpetch Daungsupawong, Viroj Wiwanitkit
doaj   +1 more source

SSO targets CD36 to regulate lipid metabolism disorders and improve SiO₂ induced fibrosis. [PDF]

Curr Res Toxicol
Wang X, Zhang Y, Hu Y, Liu X, Zhang B, Wang H, Liu H, He H.   +7 more
europepmc   +1 more source